Anthony R. Fehr

10.6k total citations · 4 hit papers
52 papers, 6.8k citations indexed

About

Anthony R. Fehr is a scholar working on Infectious Diseases, Oncology and Immunology. According to data from OpenAlex, Anthony R. Fehr has authored 52 papers receiving a total of 6.8k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Infectious Diseases, 19 papers in Oncology and 15 papers in Immunology. Recurrent topics in Anthony R. Fehr's work include SARS-CoV-2 and COVID-19 Research (26 papers), PARP inhibition in cancer therapy (16 papers) and interferon and immune responses (7 papers). Anthony R. Fehr is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (26 papers), PARP inhibition in cancer therapy (16 papers) and interferon and immune responses (7 papers). Anthony R. Fehr collaborates with scholars based in United States, Finland and Germany. Anthony R. Fehr's co-authors include Stanley Perlman, Rudragouda Channappanavar, David K. Meyerholz, Matthias Mack, Jincun Zhao, Rahul Vijay, Dong Yü, Paul B. McCray, Jeremiah Athmer and Yousef M. Alhammad and has published in prestigious journals such as Cell, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Anthony R. Fehr

49 papers receiving 6.7k citations

Hit Papers

Coronaviruses: An Overview of Their Replication and Patho... 2015 2026 2018 2022 2015 2016 2020 2019 500 1000 1.5k 2.0k 2.5k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Coronaviruses: An Overview of Their Replication and Pathogenesis
    2015 2.6k citations Anthony R. Fehr, Stanley Perlman profile →
  2. Dysregulated Type I Interferon and Inflammatory Monocyte-Macrophage Responses Cause Lethal Pneumonia in SARS-CoV-Infected Mice
    2016 1.1k citations Rudragouda Channappanavar, Anthony R. Fehr et al. Cell Host & Microbe profile →
  3. β-Coronaviruses Use Lysosomes for Egress Instead of the Biosynthetic Secretory Pathway
    2020 414 citations Sourish Ghosh, Adeline Kerviel et al. Cell profile →
  4. IFN-I response timing relative to virus replication determines MERS coronavirus infection outcomes
    2019 405 citations Rudragouda Channappanavar, Anthony R. Fehr et al. Journal of Clinical Investigation profile →

Peers

Anthony R. Fehr
Benjamin W. Neuman United States
Hin Chu Hong Kong
Jincun Zhao China
Yushun Wan China
Matthew B. Frieman United States
Natalya Vasilieva United States
Rudragouda Channappanavar United States
Jian Shang China
Young‐Jun Park United States
Bruno Coutard France
Benjamin W. Neuman United States
Anthony R. Fehr
Citations per year, relative to Anthony R. Fehr Anthony R. Fehr (= 1×) peers Benjamin W. Neuman

Countries citing papers authored by Anthony R. Fehr

Since Specialization
Citations

This map shows the geographic impact of Anthony R. Fehr's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anthony R. Fehr with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anthony R. Fehr more than expected).

Fields of papers citing papers by Anthony R. Fehr

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anthony R. Fehr. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anthony R. Fehr. The network helps show where Anthony R. Fehr may publish in the future.

Co-authorship network of co-authors of Anthony R. Fehr

This figure shows the co-authorship network connecting the top 25 collaborators of Anthony R. Fehr. A scholar is included among the top collaborators of Anthony R. Fehr based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anthony R. Fehr. Anthony R. Fehr is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Colquhoun, Iain, Joseph O’Connor, Michael J. Hageman, et al.. (2025). Identification of a series of pyrrolo-pyrimidine-based SARS-CoV-2 Mac1 inhibitors that repress coronavirus replication. mBio. 16(6). e0386524–e0386524.
3.
Bejan, Daniel S., Yating Chen, Ellen L. Suder, et al.. (2025). PARP14 is an interferon-induced host factor that promotes IFN production and affects the replication of multiple viruses. mBio. 16(10). e0229925–e0229925. 2 indexed citations
4.
Ye, Chengjin, Abhishek Asthana, Li Tan, et al.. (2024). SARS-CoV-2 nsp15 endoribonuclease antagonizes dsRNA-induced antiviral signaling. Proceedings of the National Academy of Sciences. 121(15). e2320194121–e2320194121. 18 indexed citations
5.
Sowa, Sven T., Albert Galera‐Prat, Dana Ferraris, et al.. (2024). Discovery of 2-Amide-3-methylester Thiophenes that Target SARS-CoV-2 Mac1 and Repress Coronavirus Replication, Validating Mac1 as an Antiviral Target. Journal of Medicinal Chemistry. 67(8). 6519–6536. 6 indexed citations
6.
7.
Ferraris, Dana, et al.. (2023). An Update on the Current State of SARS-CoV-2 Mac1 Inhibitors. Pathogens. 12(10). 1221–1221. 4 indexed citations
8.
9.
Fehr, Anthony R., et al.. (2022). PARP14: A key ADP-ribosylating protein in host–virus interactions?. PLoS Pathogens. 18(6). e1010535–e1010535. 15 indexed citations
10.
Ghosh, Sourish, Adeline Kerviel, Qi Qiu, et al.. (2020). β-Coronaviruses Use Lysosomes for Egress Instead of the Biosynthetic Secretory Pathway. Cell. 183(6). 1520–1535.e14. 414 indexed citations breakdown →
11.
Heer, Collin D., Yousef M. Alhammad, Mark S. Schmidt, et al.. (2020). Coronavirus infection and PARP expression dysregulate the NAD metabolome: An actionable component of innate immunity. Journal of Biological Chemistry. 295(52). 17986–17996. 137 indexed citations
12.
Channappanavar, Rudragouda, Anthony R. Fehr, Jian Zheng, et al.. (2019). IFN-I response timing relative to virus replication determines MERS coronavirus infection outcomes. Journal of Clinical Investigation. 129(9). 3625–3639. 405 indexed citations breakdown →
13.
Channappanavar, Rudragouda, Anthony R. Fehr, Jian Zheng, et al.. (2019). Relative timing of type I interferon response and virus replication determines disease outcome during respiratory virus infection. The Journal of Immunology. 202(1_Supplement). 198.4–198.4. 1 indexed citations
14.
Grunewald, Matthew, Yating Chen, Chad V. Kuny, et al.. (2019). The coronavirus macrodomain is required to prevent PARP-mediated inhibition of virus replication and enhancement of IFN expression. PLoS Pathogens. 15(5). e1007756–e1007756. 137 indexed citations
15.
Kankanamalage, Anushka C. Galasiti, Yunjeong Kim, Vishnu C. Damalanka, et al.. (2018). Structure-guided design of potent and permeable inhibitors of MERS coronavirus 3CL protease that utilize a piperidine moiety as a novel design element. European Journal of Medicinal Chemistry. 150. 334–346. 92 indexed citations
16.
Grunewald, Matthew, Anthony R. Fehr, Jeremiah Athmer, & Stanley Perlman. (2017). The coronavirus nucleocapsid protein is ADP-ribosylated. Virology. 517. 62–68. 57 indexed citations
17.
Fehr, Anthony R., Gytis Jankevicius, Ivan Ahel, & Stanley Perlman. (2017). Viral Macrodomains: Unique Mediators of Viral Replication and Pathogenesis. Trends in Microbiology. 26(7). 598–610. 88 indexed citations
18.
Channappanavar, Rudragouda, Anthony R. Fehr, Rahul Vijay, et al.. (2016). Dysregulated Type I Interferon and Inflammatory Monocyte-Macrophage Responses Cause Lethal Pneumonia in SARS-CoV-Infected Mice. Cell Host & Microbe. 19(2). 181–193. 1064 indexed citations breakdown →
19.
Fehr, Anthony R., et al.. (2013). Cyclin A Degradation by Primate Cytomegalovirus Protein pUL21a Counters Its Innate Restriction of Virus Replication. PLoS Pathogens. 9(12). e1003825–e1003825. 24 indexed citations
20.
Perng, Yi-Chieh, Zhikang Qian, Anthony R. Fehr, Baoqin Xuan, & Dong Yü. (2011). The Human Cytomegalovirus Gene UL79 Is Required for the Accumulation of Late Viral Transcripts. Journal of Virology. 85(10). 4841–4852. 53 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Benjamin W. Neuman Breakdown of academic impact, for papers by Hin Chu Breakdown of academic impact, for papers by Jincun Zhao Breakdown of academic impact, for papers by Yushun Wan Breakdown of academic impact, for papers by Matthew B. Frieman Breakdown of academic impact, for papers by Natalya Vasilieva Breakdown of academic impact, for papers by Rudragouda Channappanavar Breakdown of academic impact, for papers by Jian Shang Breakdown of academic impact, for papers by Young‐Jun Park Breakdown of academic impact, for papers by Bruno Coutard
Rankless by CCL
2026